- Home
- UVSP vs ELVN Comparison
UVSP vs ELVN Comparison
Compare UVSP & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVSP
- ELVN
- Stock Information
- Founded
- UVSP 1876
- ELVN 2016
- Country
- UVSP United States
- ELVN United States
- Employees
- UVSP N/A
- ELVN N/A
- Industry
- UVSP Major Banks
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- UVSP Finance
- ELVN Health Care
- Exchange
- UVSP Nasdaq
- ELVN Nasdaq
- Market Cap
- UVSP 881.8M
- ELVN 927.8M
- IPO Year
- UVSP 1989
- ELVN 2020
- Fundamental
- Price
- UVSP $29.05
- ELVN $21.30
- Analyst Decision
- UVSP Hold
- ELVN Strong Buy
- Analyst Count
- UVSP 3
- ELVN 5
- Target Price
- UVSP $29.00
- ELVN $39.60
- AVG Volume (30 Days)
- UVSP 91.3K
- ELVN 594.3K
- Earning Date
- UVSP 07-23-2025
- ELVN 08-12-2025
- Dividend Yield
- UVSP 3.05%
- ELVN N/A
- EPS Growth
- UVSP 11.32
- ELVN N/A
- EPS
- UVSP 2.66
- ELVN N/A
- Revenue
- UVSP $294,306,000.00
- ELVN N/A
- Revenue This Year
- UVSP $11.24
- ELVN N/A
- Revenue Next Year
- UVSP $4.30
- ELVN N/A
- P/E Ratio
- UVSP $10.85
- ELVN N/A
- Revenue Growth
- UVSP 2.88
- ELVN N/A
- 52 Week Low
- UVSP $21.17
- ELVN $13.30
- 52 Week High
- UVSP $32.75
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- UVSP 46.15
- ELVN 55.53
- Support Level
- UVSP $28.20
- ELVN $18.53
- Resistance Level
- UVSP $30.00
- ELVN $24.11
- Average True Range (ATR)
- UVSP 0.81
- ELVN 1.96
- MACD
- UVSP -0.09
- ELVN 0.15
- Stochastic Oscillator
- UVSP 35.66
- ELVN 55.68
About UVSP Univest Financial Corporation
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.